Tetrac

CAS: 67-30-1

Ref. TM-T36715

Produktinformation

• Name: Tetrac
• Synonyme: Tetraiodothyroacetic acid, 3,3',5,5'-Tetraiodothyroacetic acid, 3,3′,5,5′-Tetraiodothyroacetic acid, 3,5,3′,5′-Tetraiodothyroacetic acid, 3,5-Diiodo-4-(4-hydroxy-3,5-diiodophenoxy)benzeneacetic acid, 4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzeneacetic acid, 4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenylacetic acid, Acetic acid, (4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)- (8CI), Acetic acid, [4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-, Acide 3,5,3',5'-tetraiodothyroacetique, Acide 3,5,3',5'-tetraiodothyroacetique [French], Benzeneacetic acid, 3,5-diiodo-4-(4-hydroxy-3,5-diiodophenoxy)-, Benzeneacetic acid, 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-, Tetraiodothyroacetic acid, Thyroacetic acid, 3,3',5,5'-tetraiodo-, Thyroacetic acid, 3,3′,5,5′-tetraiodo-

Beschreibung

Tetrac (Tetraiodothyroacetic acid) is a derivative of L-thyroxine (T4), a thyroxine integrin receptor antagonist.Tetrac induces antiproliferation by blocking EGFR-mediated cell signaling in colorectal cancer cells.Tetrac blocks the effects of T4 and 3,5,3'-triiodo-L-thyronine (T3) on the cell-surface thyroxine integrin αvβ3 receptors.Tetra has anti-angiogenic, anti-tumor activity and pro-apoptotic activity.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 747.83
• Formel: C₁₄H₈I₄O₄
• Reinheit: 99.04%
• Farbe/Form: Solid